New SARS-CoV-2 Kit Simultaneously Detects Four COVID-19 Variants with Single RT PCR Test

A new real-time PCR test kit is capable of simultaneously detecting four variants of COVID-19.

Kaneka Corporation (Tokyo, Japan) has launched its new KANEKA RT-PCR Kit SARS-CoV-2 (L452R/E484Q/E484K/N501Y), a real-time PCR test kit that is capable of simultaneously detecting four variants of COVID-19. The test kit uses a reagent developed using Kaneka's molecular testing-related technologies. The reagent makes it possible to simultaneously detect four mutations of the spike protein (the N501Y, E484K, E484Q, and L452R mutations) with a single PCR test. Based on the mutation detection patterns, it can efficiently detect two variants (the Alpha, Delta, Kappa, and Beta or Gamma variants).

The PCR kit for detecting COVID-19 released by Kaneka last year received approval in June of this year as KANEKA Direct RT-PCR kit SARS-CoV-2 for use as an In-Vitro Diagnostic reagent. It is widely used in medical facilities and testing centers. By adding this new COVID-19 variant PCR test kit to its lineup, the company is aiding the rapid detection of variants and the prevention of the spread of COVID-19.

Related Links:
Kaneka Corporation 

Visit expo >

Gold Member

Universal Transport Solution

Puritan®UniTranz-RT

Verification Panels for Assay Development & QC
Seroconversion Panels

New

H.pylori Test

Humasis H.pylori Card

New

Respiratory Bacterial Panel

Real Respiratory Bacterial Panel 2